Literature DB >> 18686943

Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.

Arumugam Kodimuthali1, S Sugin Lal Jabaris, Manojit Pal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18686943     DOI： 10.1021/jm800582j

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  12 in total

Review 1.  Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.

Authors:  Fraser F Fleming; Lihua Yao; P C Ravikumar; Lee Funk; Brian C Shook
Journal:  J Med Chem       Date:  2010-08-30       Impact factor: 7.446

2.  Phosphodiesterase sequence variants may predispose to prostate cancer.

Authors:  Rodrigo B de Alexandre; Anelia D Horvath; Eva Szarek; Allison D Manning; Leticia F Leal; Fabio Kardauke; Jonathan A Epstein; Dirce M Carraro; Fernando A Soares; Tatiyana V Apanasovich; Constantine A Stratakis; Fabio R Faucz
Journal:  Endocr Relat Cancer       Date:  2015-05-15       Impact factor: 5.678

Review 3.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

4.  Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.

Authors:  Jiyun Lee; Kensei Komatsu; Byung Cheol Lee; Jae Hyang Lim; Hirofumi Jono; Haidong Xu; Hirofumi Kai; Z John Zhang; Chen Yan; Jian-Dong Li
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

5.  New 5-ylidene rhodanine derivatives based on the dispacamide A model.

Authors:  Solene Guiheneuf; Ludovic Paquin; François Carreaux; Emilie Durieu; Thierry Roisnel; Laurent Meijer; Jean-Pierre Bazureau
Journal:  Mol Divers       Date:  2014-03-02       Impact factor: 2.943

6.  Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses.

Authors:  Megha Aggarwal; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

7.  Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration.

Authors:  Matthew Hoffmann; Gondi Kumar; Peter Schafer; Dorota Cedzik; Lori Capone; Kei-Lai Fong; Zheming Gu; Dennis Heller; Hao Feng; Sekhar Surapaneni; Oscar Laskin; Anfan Wu
Journal:  Xenobiotica       Date:  2011-08-23       Impact factor: 1.908

8.  Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors.

Authors:  Ingrid Allart-Simon; Aurélie Moniot; Nicolo Bisi; Miguel Ponce-Vargas; Sandra Audonnet; Marie Laronze-Cochard; Janos Sapi; Eric Hénon; Frédéric Velard; Stéphane Gérard
Journal:  RSC Med Chem       Date:  2021-03-01

9.  Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.

Authors:  David Van Ly; Monique De Pedro; Peter James; Lucy Morgan; Judith L Black; Janette K Burgess; Brian G G Oliver
Journal:  Respir Res       Date:  2013-11-15

10.  Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors.

Authors:  Isabelle Karine da Costa Nunes; Everton Tenório de Souza; Suzana Vanessa S Cardozo; Vinicius de Frias Carvalho; Nelilma Correia Romeiro; Patrícia Machado Rodrigues E Silva; Marco Aurélio Martins; Eliezer J Barreiro; Lídia Moreira Lima
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.